Boai NKY Medical Holdings Ltd. (SHE:300109)
18.93
+0.27 (1.45%)
Apr 29, 2026, 3:04 PM CST
Boai NKY Medical Holdings Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 691.85 | 547.33 | 290.77 | 544.93 | 1,162 |
Trading Asset Securities | 23.79 | 30.98 | 34.2 | 31.99 | 201.71 |
Cash & Short-Term Investments | 715.64 | 578.31 | 324.97 | 576.92 | 1,364 |
Cash Growth | 23.75% | 77.96% | -43.67% | -57.70% | 392.94% |
Accounts Receivable | 406.47 | 411.25 | 411.5 | 477.93 | 345.87 |
Other Receivables | 19.43 | 34.55 | 56.67 | 55.38 | 73.42 |
Receivables | 425.9 | 445.8 | 468.17 | 533.31 | 419.29 |
Inventory | 318.31 | 377.48 | 309.8 | 246.96 | 230.44 |
Prepaid Expenses | - | - | - | - | 0.03 |
Other Current Assets | 69.24 | 110.16 | 84.05 | 76.11 | 61.71 |
Total Current Assets | 1,529 | 1,512 | 1,187 | 1,433 | 2,075 |
Property, Plant & Equipment | 1,812 | 1,496 | 1,317 | 844.8 | 731.25 |
Long-Term Investments | 394.21 | 648.39 | 809.39 | 609.34 | 108.65 |
Goodwill | 256.35 | 296.81 | 341.66 | 341.66 | 341.66 |
Other Intangible Assets | 174.26 | 138.67 | 137.71 | 116.1 | 115.79 |
Long-Term Deferred Tax Assets | 62.41 | 58.66 | 52.33 | 50.17 | 34.11 |
Long-Term Deferred Charges | 9.5 | 13.47 | 16.92 | 41.24 | 39.32 |
Other Long-Term Assets | 130.39 | 207.85 | 157.89 | 277.09 | 429.05 |
Total Assets | 4,368 | 4,372 | 4,020 | 3,714 | 3,875 |
Accounts Payable | 269.9 | 194.7 | 260.1 | 211.21 | 188.28 |
Accrued Expenses | 17.32 | 28.37 | 31.37 | 16.16 | 18.86 |
Short-Term Debt | 163.42 | 271.79 | 14.98 | 16.67 | 39.43 |
Current Portion of Long-Term Debt | 11.86 | 157 | 12 | 5 | 5.36 |
Current Portion of Leases | - | 0.92 | 0.82 | 1.25 | - |
Current Income Taxes Payable | 7.37 | 1.03 | 3.4 | 105.92 | 68.37 |
Current Unearned Revenue | 20.87 | 12.96 | 24.19 | 29.31 | 15.22 |
Other Current Liabilities | 28.4 | 40.37 | 80.1 | 116.5 | 137.44 |
Total Current Liabilities | 519.14 | 707.14 | 426.95 | 502.03 | 472.96 |
Long-Term Debt | 154 | 20.61 | 32.61 | 48.91 | 54.23 |
Long-Term Leases | 1.3 | 1.13 | - | 0.81 | - |
Long-Term Unearned Revenue | 35.04 | 31.45 | 35.72 | 39.95 | 24.93 |
Long-Term Deferred Tax Liabilities | 3.43 | 3.81 | 4.15 | 4.63 | 8.74 |
Other Long-Term Liabilities | 0.25 | 0.23 | 0.22 | 0.22 | 0.22 |
Total Liabilities | 713.16 | 764.37 | 499.66 | 596.55 | 561.07 |
Common Stock | 486.05 | 484.7 | 322.6 | 323.91 | 343.62 |
Additional Paid-In Capital | 2,035 | 2,039 | 2,113 | 2,078 | 2,410 |
Retained Earnings | 1,154 | 1,100 | 1,142 | 813.61 | 697.71 |
Treasury Stock | - | - | -40.08 | -86.36 | -122.79 |
Comprehensive Income & Other | 9.79 | 13.96 | 8.53 | 6.39 | -3.22 |
Total Common Equity | 3,685 | 3,638 | 3,546 | 3,136 | 3,326 |
Minority Interest | -29.59 | -30.25 | -25.96 | -18.57 | -11.6 |
Shareholders' Equity | 3,655 | 3,608 | 3,520 | 3,117 | 3,314 |
Total Liabilities & Equity | 4,368 | 4,372 | 4,020 | 3,714 | 3,875 |
Total Debt | 330.58 | 451.46 | 60.41 | 72.64 | 99.02 |
Net Cash (Debt) | 385.07 | 126.85 | 264.56 | 504.28 | 1,265 |
Net Cash Growth | 203.57% | -52.05% | -47.54% | -60.13% | - |
Net Cash Per Share | 0.79 | 0.26 | 0.55 | 0.98 | 2.52 |
Filing Date Shares Outstanding | 478.22 | 484.7 | 449.07 | 517.89 | 484.38 |
Total Common Shares Outstanding | 478.22 | 484.7 | 449.07 | 517.89 | 484.38 |
Working Capital | 1,010 | 804.61 | 760.05 | 931.28 | 1,602 |
Book Value Per Share | 7.71 | 7.51 | 7.90 | 6.05 | 6.87 |
Tangible Book Value | 3,254 | 3,202 | 3,067 | 2,678 | 2,868 |
Tangible Book Value Per Share | 6.80 | 6.61 | 6.83 | 5.17 | 5.92 |
Buildings | - | 629.29 | 593.75 | 371.75 | 356.75 |
Machinery | - | 810.17 | 695.7 | 50.21 | 437.37 |
Construction In Progress | - | 501.03 | 405.71 | 336.54 | 218.9 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.